Autopsy report · NCT01678911
Efficacy of Gralise® for Chronic Pelvic Pain
Cause of deathSlow enrollment
“Study ended due to difficulties in recruitment and low enrollment.”
Life of this trial
- Ran for about 1 year 10 months before it stopped.
- 11 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Shirley Ryan AbilityLab
- Sponsor type
- University, hospital or other
- Conditions
- Irritable Bowel Syndrome; Ulcerative Colitis; Interstitial Cystitis; Prostatitis; Pelvic Pain
- Interventions
- Gralise
- Participants
- 11
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Salvage Cryotherapy in Recurrent Prostate Cancer
“Study was ended due to low enrollment” - Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
“Study was stopped due to insufficient recruitment.” - A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
“The study was ended due to a lack of recruitment” - To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
“the study was early terminated due to lack of recruitment.” - Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement
“Study was closed due to lack of personnel for recruitment/enrollment purposes.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.